SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (6786)5/14/1999 4:59:00 PM
From: clochard  Read Replies (2) | Respond to of 7041
 
Save your breath man, Reeves is probably a schill pretending to have real interest in this dog. Even if he isn't, his statement of having only "play money" in the stock is proof enough that he is just wasting everyone's time, including his own.



To: Cacaito who wrote (6786)5/14/1999 6:22:00 PM
From: Claud B  Read Replies (1) | Respond to of 7041
 
Cacaito,

If you can show me one piece of documentation that shows "Ross"
sold his shares, I'll never dispute your views on this company again.

And when you talk about "high salaries," I guess that's a relative
term. If you're used to making $20,000 a year, (maybe you are) then
their salaries are indeed "high."

Claud



To: Cacaito who wrote (6786)5/15/1999 12:54:00 AM
From: RWReeves  Respond to of 7041
 
Good points to be raised. It is a high burn rate for a company with a relatively simple product. I am assuming that management must obey the laws of gravity and reduce burn to match prospects. You can't float a good offering much less a dilutive one in this market so they'll have ot live with what they have. I agree the other stuff is mostly flotsam.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News